Off-campus UMass Amherst users: To download campus access dissertations, please use the following link to log into our proxy server with your UMass Amherst user name and password.
Non-UMass Amherst users: Please talk to your librarian about requesting this dissertation through interlibrary loan.
Dissertations that have an embargo placed on them will not be available to anyone until the embargo expires.
Campus-Only Access for Five (5) Years
Doctor of Philosophy (PhD)
Molecular and Cellular Biology
Year Degree Awarded
Month Degree Awarded
Scott C Garman
Biochemistry | Structural Biology
Acid α-glucosidase (GAA) is required for the degradation of lysosomal glycogen. Pompe disease is an autosomal recessive disorder caused by reduced GAA activity, resulting in the accumulation of glycogen within lysosomes. The most severe form of the disease is characterized by a progressive deterioration of cardiac and skeletal muscle leading to death before two years of age. An intense interest from both the academic and pharmaceutical communities led us to determine the crystal structure of GAA. The structure provides insight into Pompe disease by examining how over 200 disease-associated point mutations perturb GAA function. To aid in the development of therapeutic approaches for Pompe disease, the structural basis for ligand binding and the catalytic mechanism were studied. The work identified a second ligand binding site distant from the active site leading to a new model of the GAA:glycogen complex. This second ligand binding site maybe useful for developing pharmacological chaperones that do not inhibit the active site. Additionally, the structures identify key interactions between GAA and NB-DNJ, a pharmacological chaperone currently in clinical trials, and identifies modifications that maybe useful for improving active site directed pharmacological chaperones for Pompe disease.
Deming, Derrick, "Structural studies of acid alpha glucosidase and Pompe disease" (2018). Doctoral Dissertations. 1430.
Available for download on Friday, March 01, 2019